Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.82 [0.71-0.94],0.00526901676125275,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BSG,Basigin,Wald ratio,1,1.32 [1.08-1.6],0.00573279973485328,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.9 [0.83-0.97],0.00748903715467058,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.07 [1.02-1.14],0.0103459268048757,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.95 [0.91-0.99],0.0104596120260308,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.26 [1.05-1.53],0.0139274291402979,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.91 [0.85-0.98],0.0151055503902795,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.9 [0.82-0.98],0.0192905603763719,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.9 [0.82-0.98],0.0196457914457532,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.91 [0.84-0.99],0.0201247766258481,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.04 [1.01-1.07],0.0219125133626476,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.67 [0.47-0.95],0.0254747475973164,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.71 [0.52-0.96],0.0281707870150224,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.06 [1.01-1.12],0.0319387685884537,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSO,Cathepsin O,Inverse variance weighted,6,0.85 [0.74-0.99],0.0349395298389269,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SDC1,Syndecan-1,Inverse variance weighted,2,1.24 [1.02-1.5],0.0349523003186236,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.2 [1.01-1.42],0.0370693145371945,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.93 [0.87-1],0.0381540126019947,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.15 [1.01-1.31],0.0413999899702263,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OGN,Mimecan,Inverse variance weighted,30,0.94 [0.89-1],0.0416401537798409,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.17 [1.01-1.36],0.0421641271028462,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,APOA2,Apolipoprotein A-II,Wald ratio,1,0.65 [0.43-0.99],0.0444832076879469,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.61 [0.37-0.99],0.0450516581145608,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.88 [0.77-1],0.0513237874206142,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.94 [0.87-1],0.05162189732771,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.16 [1-1.35],0.053630863651171,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.74 [0.97-3.13],0.062861613107346,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.77 [0.58-1.01],0.0631751121554371,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PGF,Placenta growth factor,Inverse variance weighted,2,1.94 [0.95-3.93],0.0670221494757636,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.91 [0.82-1.01],0.0674727241002841,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GUCA2A,Guanylin,Inverse variance weighted,9,1.12 [0.99-1.26],0.0685189733656686,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ANXA10,Annexin A10,Wald ratio,1,0.61 [0.36-1.04],0.0705258853800784,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.16 [0.99-1.36],0.0735644640008726,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.89 [0.78-1.01],0.0739217544347564,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.92 [0.83-1.01],0.0785710938557762,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.9 [0.79-1.01],0.0815895648806994,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REN,Renin,Inverse variance weighted,4,1.09 [0.99-1.21],0.086204428175683,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.19 [0.97-1.47],0.0880150627949282,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.06 [0.99-1.14],0.0909110202986976,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.32 [0.95-1.83],0.0996601862921948,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CFD,Complement factor D,Inverse variance weighted,11,0.93 [0.85-1.02],0.104066858230129,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.08 [0.98-1.18],0.107397859648481,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.98-1.19],0.108084977826726,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPON2,Spondin-2,Inverse variance weighted,4,1.1 [0.98-1.24],0.109336686733325,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MDK,Midkine,Inverse variance weighted,4,1.21 [0.96-1.54],0.112235009478236,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GRN,Progranulin,Inverse variance weighted,7,1.07 [0.98-1.17],0.117046988368084,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.31 [0.93-1.83],0.118250792495158,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.87 [0.73-1.04],0.11847543504967,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NRP2,Neuropilin-2,Inverse variance weighted,11,1.08 [0.98-1.18],0.119554757717345,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.05 [0.99-1.13],0.120900316694371,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.93 [0.85-1.02],0.121780062564727,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAYN,Layilin,Inverse variance weighted,20,1.07 [0.98-1.17],0.126299342984391,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.95 [0.89-1.02],0.131075924498013,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.96 [0.91-1.01],0.137665484717763,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD302,CD302 antigen,Inverse variance weighted,9,0.93 [0.85-1.02],0.14162107322817,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DSC2,Desmocollin-2,Inverse variance weighted,9,0.93 [0.84-1.03],0.14427838589564,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LGALS4,Galectin-4,Inverse variance weighted,4,0.88 [0.74-1.04],0.146775002141125,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RETN,Resistin,Inverse variance weighted,9,0.96 [0.9-1.02],0.153856827413888,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.88 [0.74-1.05],0.165117591221354,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.57 [0.26-1.26],0.167445204155958,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.96 [0.91-1.02],0.171323095319146,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CSTB,Cystatin-B,Inverse variance weighted,28,0.96 [0.9-1.02],0.178296578678925,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.91 [0.78-1.05],0.188158557316852,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.87 [0.71-1.07],0.192750619403421,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.95 [0.87-1.03],0.192846036793354,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.66 [0.35-1.25],0.203450391857921,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.93 [0.82-1.04],0.208084465073147,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COLEC12,Collectin-12,Inverse variance weighted,11,0.94 [0.84-1.04],0.211705991587189,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.06 [0.96-1.18],0.225956138329878,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPON1,Spondin-1,Inverse variance weighted,21,1.04 [0.97-1.11],0.227344556876298,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.11 [0.94-1.31],0.235620754277322,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.06 [0.96-1.17],0.239190051847494,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EDN1,Endothelin-1,Inverse variance weighted,3,0.93 [0.82-1.05],0.239296297064613,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KLK11,Kallikrein-11,Inverse variance weighted,6,1.05 [0.97-1.15],0.240767821083149,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.91 [0.77-1.07],0.244404457630504,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.96 [0.89-1.03],0.245457104357872,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.78 [0.51-1.19],0.245636732157587,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.17 [0.89-1.54],0.250668181610207,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CST3,Cystatin-C,Inverse variance weighted,10,1.06 [0.96-1.17],0.251128651716617,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.95 [0.88-1.03],0.253798431093717,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.96 [0.88-1.03],0.260276709022417,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.93 [0.82-1.06],0.263024501321371,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHGA,Chromogranin-A,Inverse variance weighted,3,0.89 [0.72-1.09],0.264474353806213,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.97 [0.93-1.02],0.266639907586453,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.04 [0.97-1.13],0.2698597292733,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LGALS9,Galectin-9,Inverse variance weighted,26,1.03 [0.97-1.09],0.275285653193918,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD276,CD276 antigen,Inverse variance weighted,20,1.03 [0.98-1.09],0.28701875734715,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.97 [0.92-1.02],0.288976892608434,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.07 [0.94-1.21],0.297474082371896,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.11 [0.91-1.34],0.299261957274944,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.97 [0.93-1.02],0.301064237307252,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OCLN,Occludin,Inverse variance weighted,2,1.12 [0.9-1.38],0.305339016932661,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.97 [0.91-1.03],0.306491975098431,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.92 [0.78-1.08],0.308604663828157,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.06 [0.94-1.19],0.317713263997648,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.03 [0.97-1.08],0.318037481081189,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PALM2,Paralemmin-2,Inverse variance weighted,8,0.93 [0.81-1.07],0.321323508409943,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.05 [0.95-1.17],0.335040045462142,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LMNB2,Lamin-B2,Wald ratio,1,0.72 [0.37-1.41],0.336782063703115,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.95 [0.86-1.06],0.347969154804303,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.97-1.1],0.351760603505858,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.95 [0.86-1.06],0.357153061494681,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.03 [0.97-1.08],0.366373649343353,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN5,CCN family member 5,Inverse variance weighted,8,0.91 [0.73-1.12],0.366819195798295,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PI3,Elafin,Inverse variance weighted,10,1.04 [0.96-1.13],0.368776870001708,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.08 [0.91-1.29],0.373050332718723,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.92 [0.77-1.1],0.373824423490062,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NRP1,Neuropilin-1,Inverse variance weighted,12,0.97 [0.9-1.04],0.375457619016975,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD83,CD83 antigen,Inverse variance weighted,5,0.94 [0.82-1.08],0.3784193639221,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.4 [0.66-2.95],0.379962756271991,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.05 [0.95-1.15],0.38081511443909,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.96 [0.89-1.05],0.384994632305607,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.97 [0.92-1.04],0.397941370339812,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.97 [0.89-1.05],0.402490611423836,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.97 [0.89-1.05],0.431017414201031,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.94 [0.8-1.1],0.438747330376856,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.95 [0.85-1.08],0.454548923977549,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN4,CCN family member 4,Inverse variance weighted,27,0.98 [0.93-1.03],0.463791199951386,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MMP7,Matrilysin,Inverse variance weighted,13,0.96 [0.87-1.07],0.475071234042502,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KLK4,Kallikrein-4,Inverse variance weighted,17,1.03 [0.96-1.1],0.476665580594403,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.91 [0.7-1.18],0.478219453516708,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.01 [0.98-1.05],0.480450379668153,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.93 [0.76-1.14],0.48202176289825,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.97-1.07],0.48526702612638,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.95 [0.84-1.09],0.491739925945274,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.06 [0.9-1.26],0.492043046507347,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.04 [0.93-1.17],0.49327187836391,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.98 [0.91-1.05],0.4952257455243,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.04 [0.93-1.17],0.500549694337327,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.94-1.03],0.501453034221122,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.94 [0.77-1.13],0.503241449655051,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RSPO3,R-spondin-3,Inverse variance weighted,6,1.06 [0.89-1.28],0.505678935015825,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.09 [0.84-1.41],0.506158249114018,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.95 [0.82-1.1],0.507221409612676,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.99 [0.95-1.02],0.507387061040747,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AGRN,Agrin,Inverse variance weighted,17,0.97 [0.88-1.06],0.507920495086093,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.04 [0.92-1.17],0.510373213492404,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.97 [0.87-1.07],0.515429690090276,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.96-1.02],0.521156422753958,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.07 [0.87-1.32],0.524884501253186,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.92 [0.72-1.19],0.52632921885564,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.02 [0.96-1.09],0.529027385938853,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.03 [0.95-1.11],0.535758220808723,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.03 [0.93-1.15],0.546196053196179,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.94 [0.78-1.14],0.548968331679536,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.01 [0.97-1.06],0.555025925098659,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.96 [0.86-1.09],0.555034566232789,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.98 [0.91-1.05],0.558557519302998,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.97 [0.88-1.07],0.559076838673921,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.97-1.06],0.559696775509125,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.03 [0.94-1.12],0.560456697315867,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.87 [0.53-1.41],0.564708909686622,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.98 [0.9-1.06],0.565531228112889,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.13 [0.74-1.73],0.567268706948697,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THBD,Thrombomodulin,Inverse variance weighted,5,1.05 [0.89-1.23],0.572757877312014,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NECTIN4,Nectin-4,Inverse variance weighted,7,0.97 [0.87-1.08],0.573625249398521,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NECTIN2,Nectin-2,Inverse variance weighted,5,0.95 [0.81-1.13],0.580754271781049,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNC,Tenascin,Inverse variance weighted,12,1.03 [0.93-1.14],0.584024568427831,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.05 [0.88-1.24],0.58756961157167,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.99 [0.95-1.03],0.589823647889471,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.98 [0.9-1.06],0.590009371053171,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.88 [0.55-1.41],0.600658729767094,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.02 [0.95-1.08],0.602547894087269,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.14 [0.69-1.88],0.606910398955015,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.93 [0.68-1.25],0.614227506615785,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.04 [0.88-1.24],0.623031853927271,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.01 [0.97-1.05],0.625872341132353,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.09 [0.76-1.56],0.631546653385173,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SEPTIN8,Septin-8,Inverse variance weighted,2,1.1 [0.75-1.6],0.636394322989622,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.02 [0.95-1.09],0.651940429356171,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.92-1.05],0.652173514917989,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.01 [0.98-1.04],0.654131847397961,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.05 [0.83-1.33],0.668755598125853,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.1 [0.7-1.73],0.673510509915098,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD48,CD48 antigen,Inverse variance weighted,18,1.01 [0.96-1.07],0.676260698651368,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.92 [0.62-1.36],0.678502636444627,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PSAP,Prosaposin,Inverse variance weighted,5,0.98 [0.86-1.1],0.683620837050396,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BCAN,Brevican core protein,Inverse variance weighted,3,0.97 [0.85-1.11],0.686106734460353,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.04 [0.86-1.25],0.703380298719699,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.92-1.06],0.708119801238715,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.02 [0.93-1.11],0.714356471321155,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.03 [0.87-1.22],0.719783042096357,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.93-1.11],0.720255269092066,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.97-1.05],0.721356589932664,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.97 [0.8-1.17],0.724218254292302,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.01 [0.94-1.1],0.725104762717045,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.04 [0.84-1.28],0.725565733053004,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.06 [0.76-1.48],0.732261788856455,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.98 [0.88-1.1],0.737000783390817,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.95 [0.7-1.29],0.742492021857588,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.89 [0.45-1.77],0.743513667643566,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.99 [0.9-1.08],0.746979989738078,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.93 [0.59-1.47],0.751780730698172,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.94-1.05],0.754273362803642,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.99 [0.92-1.06],0.75941162429822,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.94 [0.61-1.43],0.760162640944445,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.03 [0.86-1.23],0.762978063905941,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.96 [0.72-1.27],0.770524261357417,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.01 [0.93-1.1],0.777059018031588,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.99 [0.92-1.06],0.778427457787935,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.93-1.05],0.78826061159104,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.02 [0.89-1.17],0.791505229788534,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.99 [0.94-1.05],0.797431304849841,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CDH1,Cadherin-1,Wald ratio,1,1.08 [0.6-1.94],0.797898278920311,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.08 [0.57-2.04],0.809694495004789,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.01 [0.93-1.1],0.828154505815896,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN3,CCN family member 3,Inverse variance weighted,19,1.01 [0.91-1.13],0.829150845535318,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.99 [0.93-1.06],0.834524961807065,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.98 [0.85-1.14],0.837257476753299,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.01 [0.92-1.11],0.837953206715388,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PRSS8,Prostasin,Inverse variance weighted,5,0.98 [0.81-1.19],0.840124672942554,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.76-1.25],0.847952884940837,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.01 [0.91-1.12],0.850425436167051,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.99 [0.91-1.09],0.853979395561356,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.99 [0.94-1.05],0.860743363779337,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSD,Cathepsin D,Inverse variance weighted,17,0.99 [0.92-1.07],0.861026722503671,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AMBP,Protein AMBP,Inverse variance weighted,3,1.04 [0.68-1.58],0.867183229952554,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.95-1.05],0.876639297592495,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.02 [0.8-1.29],0.892688101956974,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.01 [0.89-1.15],0.895960950787163,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1 [0.95-1.06],0.900066793395646,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.88-1.15],0.903829045669233,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1 [0.94-1.06],0.910962304329359,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.99 [0.8-1.21],0.911956539153887,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.04 [0.51-2.11],0.914964533577352,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.94-1.08],0.916869608889132,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.99 [0.89-1.11],0.920468135692289,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PTN,Pleiotrophin,Inverse variance weighted,4,1.01 [0.77-1.34],0.924593603655764,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.01 [0.86-1.18],0.93094665553768,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.02 [0.66-1.57],0.934920647710297,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1 [0.9-1.12],0.938312126198948,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1 [0.9-1.12],0.941087944267764,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1 [0.93-1.06],0.943248948031091,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.77-1.28],0.959857373574018,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1 [0.91-1.09],0.963365317060593,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1 [0.91-1.09],0.966864127295688,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1 [0.84-1.2],0.97370895190049,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AREG,Amphiregulin,Inverse variance weighted,3,1 [0.84-1.2],0.978560183164943,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1 [0.82-1.21],0.98301263501789,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.92-1.08],0.985757004096423,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSL,Cathepsin L1,Wald ratio,1,1 [0.55-1.8],0.987566364202053,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1 [0.9-1.11],0.991737754733168,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1 [0.79-1.26],0.993117918636744,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1 [0.75-1.34],0.998392471766753,cis
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.39 [1.13-1.71],0.00157008598364732,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CDH1,Cadherin-1,Inverse variance weighted,16,0.88 [0.81-0.96],0.00402348660029092,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.78 [1.19-2.66],0.00530935357622472,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.14 [1.04-1.26],0.00559934480174875,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.22 [1.04-1.44],0.0175490102626375,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.13 [1.02-1.26],0.0196315345797085,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MDK,Midkine,Inverse variance weighted,14,1.23 [1.03-1.46],0.0209334020922064,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,2.14 [1.08-4.26],0.0295297735924844,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.04 [1-1.07],0.0306303970661132,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.52 [1.03-2.23],0.0333135975094058,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OGN,Mimecan,Inverse variance weighted,37,0.94 [0.89-1],0.0340521439010809,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.48 [1.03-2.12],0.0353779840917349,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.43 [1.02-1.99],0.0357442732522142,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GRN,Progranulin,Inverse variance weighted,46,1.05 [1-1.11],0.0398593715204706,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.84 [0.71-0.99],0.0402774375305732,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.25 [1-1.56],0.0507709588550159,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.92 [0.84-1.01],0.0679731301958002,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.68 [0.45-1.03],0.0716161557201213,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.82 [0.65-1.02],0.0805618881751441,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.46 [0.95-2.23],0.0811835319973469,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.11 [0.99-1.25],0.0818779132387117,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.12 [0.99-1.28],0.0820572084404558,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DSC2,Desmocollin-2,Inverse variance weighted,16,0.92 [0.84-1.01],0.0916385242860482,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.68 [0.91-3.1],0.0945213140560455,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REN,Renin,Inverse variance weighted,8,0.76 [0.54-1.06],0.102205337239608,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.25 [0.95-1.64],0.11813134830978,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.83 [0.66-1.05],0.122939665824141,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.44 [0.91-2.3],0.123105569810312,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.92 [0.82-1.03],0.129593357278396,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.13 [0.96-1.33],0.134117731596079,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PGF,Placenta growth factor,Inverse variance weighted,5,0.78 [0.56-1.08],0.137348214223665,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.88 [0.75-1.04],0.138457873685991,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.74 [0.5-1.11],0.143850551152249,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.14 [0.95-1.37],0.145678899648557,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.15 [0.95-1.4],0.152910999891753,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.87 [0.72-1.05],0.154004582296867,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.88 [0.73-1.05],0.158416032575358,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.1 [0.96-1.27],0.160156258776403,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.24 [0.92-1.69],0.161422971558888,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.89 [0.75-1.05],0.165582276191925,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CFD,Complement factor D,Wald ratio,1,1.49 [0.84-2.64],0.1701415465296,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.93 [0.83-1.03],0.175095627500946,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.16 [0.93-1.46],0.185728131124409,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PSAP,Prosaposin,Inverse variance weighted,13,0.94 [0.85-1.03],0.18930266197803,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.16 [0.93-1.44],0.193278122797699,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.85 [0.66-1.09],0.201278109311775,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.2 [0.91-1.59],0.201534089127841,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.94 [0.85-1.03],0.201627717301334,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.79 [0.56-1.13],0.201916075502012,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THBD,Thrombomodulin,Inverse variance weighted,11,1.07 [0.96-1.19],0.20639215807195,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RETN,Resistin,Inverse variance weighted,19,0.93 [0.83-1.04],0.207279717149585,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.84 [0.64-1.11],0.220834940380846,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.95 [0.87-1.03],0.222198908717398,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.92 [0.81-1.05],0.235660585768841,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SDC1,Syndecan-1,Inverse variance weighted,12,0.91 [0.78-1.06],0.237176087927952,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.14 [0.92-1.42],0.237748163915902,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.09 [0.95-1.25],0.238594343654675,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.93-1.02],0.25919792476049,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CSTB,Cystatin-B,Inverse variance weighted,23,0.96 [0.9-1.03],0.261785554039224,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.05 [0.96-1.15],0.265762220178526,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PALM2,Paralemmin-2,Inverse variance weighted,9,0.93 [0.81-1.06],0.268584611122721,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.1 [0.92-1.32],0.280664968541199,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LGALS9,Galectin-9,Inverse variance weighted,36,1.03 [0.97-1.09],0.280729930358459,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.22 [0.85-1.75],0.282807815173947,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.17 [0.88-1.55],0.285200998651743,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.86 [0.65-1.14],0.287943346468429,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MMP7,Matrilysin,Wald ratio,1,1.14 [0.89-1.47],0.290906840284051,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,WNT9A,Protein Wnt-9a,Wald ratio,1,1.51 [0.7-3.24],0.29515331227566,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.95 [0.85-1.05],0.30769287403575,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PTN,Pleiotrophin,Inverse variance weighted,3,1.16 [0.87-1.56],0.309574349754726,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.14 [0.89-1.46],0.310512623268838,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNC,Tenascin,Inverse variance weighted,57,1.03 [0.97-1.09],0.311050013955608,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BCAN,Brevican core protein,Inverse variance weighted,12,1.09 [0.92-1.28],0.320921804735631,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AGRN,Agrin,Inverse variance weighted,14,0.92 [0.78-1.09],0.330683323473077,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PI3,Elafin,Inverse variance weighted,18,1.04 [0.96-1.12],0.334603321477328,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.89 [0.7-1.13],0.337300704512383,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.92 [0.78-1.09],0.34674578543398,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.94 [0.81-1.08],0.361560751146417,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD83,CD83 antigen,Inverse variance weighted,14,0.94 [0.81-1.08],0.363865194128774,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.16 [0.84-1.62],0.368041589663895,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.19 [0.82-1.72],0.368629425118725,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.04 [0.95-1.15],0.373440713267213,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.16 [0.83-1.63],0.374580280791427,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.16 [0.83-1.63],0.389228676938759,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NRP1,Neuropilin-1,Inverse variance weighted,14,1.09 [0.9-1.31],0.393230883717173,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.94 [0.81-1.09],0.399034666837785,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.8 [0.47-1.37],0.414869187518868,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PRSS8,Prostasin,Inverse variance weighted,14,1.06 [0.92-1.23],0.422419203810855,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.91 [0.72-1.15],0.426277195858759,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.91 [0.72-1.15],0.430367968535058,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.93 [0.76-1.12],0.432879744479549,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.78-1.11],0.434450886810298,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.07 [0.9-1.28],0.438624012394803,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NRP2,Neuropilin-2,Inverse variance weighted,14,1.09 [0.87-1.38],0.444123947303145,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.04 [0.94-1.14],0.449161453077576,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.11 [0.84-1.46],0.451071702969617,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,0.93 [0.77-1.12],0.451623814990329,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.09 [0.86-1.39],0.455555813254797,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NECTIN4,Nectin-4,Inverse variance weighted,4,0.89 [0.65-1.22],0.458571537796705,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.74 [0.33-1.65],0.458888604483578,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.97-1.06],0.45947119654777,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSL,Cathepsin L1,Inverse variance weighted,29,0.96 [0.87-1.07],0.460256171991776,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPON2,Spondin-2,Inverse variance weighted,3,1.15 [0.79-1.66],0.464054522394026,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.1 [0.85-1.41],0.465099652826548,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.07 [0.89-1.28],0.4655559103561,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.84 [0.53-1.35],0.472357775457757,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.94 [0.79-1.12],0.477685034524124,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.93 [0.76-1.14],0.482492393935667,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.94 [0.79-1.12],0.48633499327296,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AREG,Amphiregulin,Inverse variance weighted,5,1.09 [0.85-1.39],0.489373598864463,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.07 [0.88-1.29],0.495564945648487,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LGALS4,Galectin-4,Inverse variance weighted,15,0.98 [0.91-1.05],0.497670686064227,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.8 [0.41-1.56],0.51144070750786,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SPON1,Spondin-1,Inverse variance weighted,4,0.85 [0.52-1.38],0.513780364636622,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.86 [0.55-1.35],0.515091196625349,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.09 [0.84-1.4],0.518599665314674,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.04 [0.91-1.19],0.523427576834699,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.94 [0.77-1.14],0.529146430422601,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.97 [0.88-1.07],0.532714485855213,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.94 [0.76-1.15],0.537833060997126,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.98 [0.93-1.04],0.540526761639692,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD276,CD276 antigen,Inverse variance weighted,24,0.97 [0.87-1.08],0.542178655685407,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CHGA,Chromogranin-A,Inverse variance weighted,5,0.9 [0.65-1.26],0.548462881217663,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.98 [0.92-1.04],0.555365075150484,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.96 [0.84-1.1],0.572787822969318,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CST3,Cystatin-C,Inverse variance weighted,3,1.17 [0.67-2.04],0.579805022629644,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.05 [0.89-1.23],0.579850127931392,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAYN,Layilin,Inverse variance weighted,3,1.15 [0.7-1.89],0.582390653452146,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.04 [0.9-1.21],0.585295638462883,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.1 [0.78-1.55],0.589036274410746,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.93 [0.72-1.21],0.592385317299864,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.08 [0.81-1.44],0.593555869363581,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,1.08 [0.82-1.41],0.596695313764242,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.91 [0.64-1.3],0.601547237887331,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.89 [0.59-1.36],0.603737494193358,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.05 [0.86-1.29],0.609479902593447,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.98 [0.9-1.06],0.61338041866888,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.93 [0.7-1.24],0.616901167199082,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.11 [0.74-1.67],0.619780546564258,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.15 [0.66-2.01],0.628166649041609,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.01 [0.96-1.07],0.631932461609786,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,AMBP,Protein AMBP,Inverse variance weighted,5,1.07 [0.81-1.42],0.636909331702919,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SEPTIN8,Septin-8,Inverse variance weighted,4,1.08 [0.79-1.47],0.644099272428482,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NECTIN2,Nectin-2,Inverse variance weighted,3,1.13 [0.67-1.89],0.64671738364965,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.98 [0.91-1.06],0.655323651457484,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KLK4,Kallikrein-4,Inverse variance weighted,5,0.92 [0.64-1.33],0.656735893502388,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.94-1.04],0.65849582638353,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.08 [0.78-1.49],0.663196057235266,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.97 [0.85-1.11],0.663479489022409,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.92 [0.63-1.34],0.6695450763786,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.96-1.06],0.671215554777872,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.05 [0.83-1.33],0.671333026003751,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.1 [0.7-1.73],0.673510509915098,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.95 [0.77-1.19],0.67677956678251,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.05 [0.85-1.29],0.677608604914115,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.04 [0.86-1.27],0.682191889955404,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN4,CCN family member 4,Inverse variance weighted,29,0.99 [0.93-1.05],0.682899476738347,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.06 [0.81-1.39],0.683708687374019,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSO,Cathepsin O,Inverse variance weighted,19,0.98 [0.91-1.06],0.686611432660814,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.04 [0.85-1.27],0.689318399385042,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSD,Cathepsin D,Inverse variance weighted,7,1.07 [0.77-1.49],0.691155440712522,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.97 [0.85-1.11],0.692051587544263,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.11 [0.67-1.82],0.693946280016117,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.97 [0.82-1.15],0.700944108530214,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.02 [0.94-1.1],0.709537626626915,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.09 [0.69-1.71],0.710621956655639,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.98 [0.86-1.11],0.713917322883638,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.26 [0.36-4.44],0.716033834422732,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BSG,Basigin,Inverse variance weighted,6,0.95 [0.71-1.27],0.71700173388271,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.03 [0.87-1.22],0.719783042096357,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.02 [0.91-1.15],0.721356466881029,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.91 [0.56-1.5],0.72298548593289,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.95 [0.74-1.23],0.723913019613901,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.94 [0.68-1.31],0.724647507658619,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GUCA2A,Guanylin,Inverse variance weighted,7,0.97 [0.8-1.17],0.729651561246266,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.03 [0.88-1.2],0.736301944001911,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.99 [0.92-1.06],0.741506766155082,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.03 [0.88-1.19],0.745524335859493,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.02 [0.9-1.16],0.747174119227007,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LMNB2,Lamin-B2,Inverse variance weighted,8,1.04 [0.84-1.28],0.750013050291613,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COLEC12,Collectin-12,Inverse variance weighted,3,1.11 [0.59-2.06],0.751838947445191,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.94-1.1],0.751932699761253,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.96 [0.75-1.23],0.755311145730361,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.13 [0.53-2.38],0.756250635809199,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.95 [0.66-1.35],0.760375306046392,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.03 [0.86-1.22],0.763495664695059,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.97 [0.79-1.19],0.767815352760745,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.99 [0.93-1.05],0.773770544101546,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.09 [0.61-1.93],0.774569177242221,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD302,CD302 antigen,Inverse variance weighted,11,0.98 [0.86-1.12],0.77504728296053,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.97 [0.77-1.22],0.77772974997202,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IL6,Interleukin-6,Inverse variance weighted,6,0.98 [0.86-1.12],0.778435918806326,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RSPO3,R-spondin-3,Inverse variance weighted,5,0.97 [0.77-1.22],0.782343204437207,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.95 [0.68-1.33],0.78422964550899,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.95 [0.67-1.36],0.784825296963781,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.03 [0.84-1.26],0.787726390975493,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,OCLN,Occludin,Inverse variance weighted,2,1.06 [0.67-1.68],0.789228548965755,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD27,CD27 antigen,Inverse variance weighted,9,1.04 [0.79-1.35],0.791976565874854,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.03 [0.81-1.31],0.793388596750345,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.98 [0.82-1.17],0.794588931635423,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.01 [0.92-1.11],0.79636562652801,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.02 [0.88-1.18],0.797280000704835,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.98 [0.83-1.15],0.805493234076635,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.99 [0.94-1.05],0.806849358624055,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.96 [0.69-1.33],0.808007902624786,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.98 [0.85-1.14],0.808132767697752,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.94-1.05],0.808331712387214,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.95 [0.59-1.51],0.814943109117378,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.99 [0.88-1.1],0.818332861954224,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.02 [0.83-1.26],0.825308487251917,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.99 [0.88-1.11],0.827269121510548,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN3,CCN family member 3,Inverse variance weighted,17,1.01 [0.91-1.12],0.829985524523111,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.06 [0.63-1.77],0.839051691186739,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.96 [0.65-1.41],0.841292656316416,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.93-1.06],0.841681862457159,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.02 [0.87-1.18],0.84772091213051,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.01 [0.94-1.07],0.864917053559342,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.02 [0.77-1.35],0.874715945463745,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.01 [0.91-1.11],0.881599118268919,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.95 [0.51-1.78],0.882224582059902,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.99 [0.81-1.2],0.88304895745759,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.02 [0.82-1.26],0.888198242124074,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.98 [0.7-1.36],0.888776344762,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.98 [0.76-1.27],0.891863867486344,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.04 [0.62-1.72],0.893013446293789,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.82-1.19],0.901849743927818,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.02 [0.76-1.36],0.902601762804966,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.97 [0.61-1.55],0.911959299119284,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.99 [0.86-1.14],0.912836596988944,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.99 [0.75-1.29],0.913478933184484,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.99 [0.77-1.27],0.916978717161334,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCN5,CCN family member 5,Inverse variance weighted,12,0.99 [0.89-1.11],0.921655155854073,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.01 [0.77-1.34],0.929554895483621,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD48,CD48 antigen,Inverse variance weighted,14,0.99 [0.85-1.16],0.937612460725706,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.99 [0.76-1.29],0.93774389765142,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1 [0.87-1.16],0.954083705187192,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1 [0.85-1.19],0.95554760108605,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1 [0.88-1.14],0.955779332840683,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.01 [0.83-1.21],0.957077106960691,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.99 [0.73-1.35],0.960379274207053,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.99 [0.77-1.29],0.964998198495924,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.99 [0.69-1.44],0.970539620585407,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.02 [0.32-3.23],0.975815369093672,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1 [0.81-1.23],0.978498889947155,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,DLL1,Delta-like protein 1,Inverse variance weighted,6,1 [0.78-1.29],0.97931042889351,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1 [0.92-1.09],0.983123097906625,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.99 [0.42-2.37],0.98491877760813,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1 [0.88-1.14],0.990243584663839,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1 [0.62-1.61],0.991718107023623,trans
Chapter IX Diseases of the circulatory system,I9_SEQULAE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1 [0.51-1.98],0.997596738015789,trans
